UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012914
Receipt number R000015028
Scientific Title Investigation of incretin's effect using clamp method
Date of disclosure of the study information 2014/01/21
Last modified on 2014/01/21 21:37:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of incretin's effect using clamp method

Acronym

Kobe Insulin Clearance Study

Scientific Title

Investigation of incretin's effect using clamp method

Scientific Title:Acronym

Kobe Insulin Clearance Study

Region

Japan


Condition

Condition

diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of the incretin-related drug's effect on insulin / CPR ratio of the first phase of the hyperglycemic clamp

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

the ratio of the area under the curve of IRI / CPR under first phase of hyperglycemic clamp

Key secondary outcomes



Base

Study type


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

hyperglycemic clamp without pre-treatment

Interventions/Control_2

hyperglycemic clamp after 30 min Lixisenatide 20 micro g SI

Interventions/Control_3

hyperglycemic clamp after sitagliptin 50 mg PO for 7days

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Adult NGT

Key exclusion criteria

1) drug allergy for Lixisenatide or Sitagliptin
2) Liver or renal impairment
3) Pregmant or breast feeding

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiko Sakaguchi

Organization

Kobe University School of Medicine

Division name

Diabetes and Endocrinology

Zip code


Address

7-5-1Kusunoki-Cho, Chuo-Ku, Kobe

TEL

078-382-5861

Email

kzhkskgc@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuhiko Sakaguchi

Organization

Kobe University School of Medicine

Division name

Diabetes and Endocrinology

Zip code


Address

7-5-1Kusunoki-Cho, Chuo-Ku, Kobe

TEL

078-382-5861

Homepage URL


Email

kzhkskgc@med.kobe-u.ac.jp


Sponsor or person

Institute

kobe university School of medicine
Diabetes and Endocrinology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 01 Month 21 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 01 Month 21 Day

Last modified on

2014 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015028


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name